+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
LAG-3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
AXL Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

AXL Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
P53 Antigen Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

P53 Antigen Modulators - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TIGIT Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

TIGIT Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CD47 Antigen Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

CD47 Antigen Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CD137 Agonist Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

CD137 Agonist Antibody - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
mTORC-2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

mTORC-2 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Retinoic Acid Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Retinoic Acid Receptor Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TGF-Beta Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

TGF-Beta Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
CDK12 Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

CDK12 Inhibitor- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Oligodendroglioma - Pipeline Insight, 2025 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Hepatic - Colorectal Metastasis - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatic - Colorectal Metastasis - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2025

  • Report
  • April 2025
  • 280 Pages
  • Global
From
Metastatic Liver Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Liver Cancer- Pipeline Insight, 2025

  • Report
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more